Long-term metabolic consequences of switching from protease inhibitors to efavirenz in therapy for human immunodeficiency virus-infected patients with lipoatrophy

  1. Estrada, V.
  2. De Villar, N.G.P.
  3. Martínez Larrad, M.T.
  4. González López, A.
  5. Fernández, C.
  6. Serrano-Rios, M.
Aldizkaria:
Clinical Infectious Diseases

ISSN: 1058-4838

Argitalpen urtea: 2002

Alea: 35

Zenbakia: 1

Orrialdeak: 69-76

Mota: Artikulua

DOI: 10.1086/340863 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus